Oruka Therapeutics Inc (NASDAQ: ORKA) kicked off on Friday, up 13.11% from the previous trading day, before settling in for the closing price of $28.15. Over the past 52 weeks, ORKA has traded in a range of $5.49-$32.28.
Healthcare Sector giant saw their annual sales surged by 36.88% over the last five years. While this was happening, its average annual earnings per share was recorded 43.49%. With a float of $42.67 million, this company’s outstanding shares have now reached $48.38 million.
Oruka Therapeutics Inc (ORKA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Oruka Therapeutics Inc is 11.86%, while institutional ownership is 85.36%. The most recent insider transaction that took place on Dec 19 ’25, was worth 214,293. In this transaction Chief Medical Officer of this company sold 7,000 shares at a rate of $30.61, taking the stock ownership to the 1,518 shares. Before that another transaction happened on Dec 19 ’25, when Company’s Officer proposed sale 28,000 for $28.15, making the entire transaction worth $788,200.
Oruka Therapeutics Inc (ORKA) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.49 earnings per share (EPS), higher than consensus estimate (set at -0.98) by 0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.79% during the next five years compared to 36.88% growth over the previous five years of trading.
Oruka Therapeutics Inc (NASDAQ: ORKA) Trading Performance Indicators
Take a look at Oruka Therapeutics Inc’s (ORKA) current performance indicators. Last quarter, stock had a quick ratio of 16.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.56 in one year’s time.
Technical Analysis of Oruka Therapeutics Inc (ORKA)
Analysing the last 5-days average volume posted by the [Oruka Therapeutics Inc, ORKA], we can find that recorded value of 1.35 million was better than the volume posted last year of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 34.77%.
During the past 100 days, Oruka Therapeutics Inc’s (ORKA) raw stochastic average was set at 97.74%, which indicates a significant increase from 92.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.94 in the past 14 days, which was higher than the 1.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.37, while its 200-day Moving Average is $16.78. Now, the first resistance to watch is $33.33. This is followed by the second major resistance level at $34.83. The third major resistance level sits at $37.44. If the price goes on to break the first support level at $29.22, it is likely to go to the next support level at $26.61. Now, if the price goes above the second support level, the third support stands at $25.11.
Oruka Therapeutics Inc (NASDAQ: ORKA) Key Stats
The company with the Market Capitalisation of 1.54 billion has total of 48,409K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -83,720 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -30,280 K.
